Skip to main content
Tech.euFundingExplorerBeta

Amal Therapeutics

Exited

Developing and progressing therapeutic cancer vaccines

Geneva, SwitzerlandFounded 2012amaltherapeutics.com ↗
Healthtech
← All companies
Total raised
€2.8M
€2,800,000
Funding rounds
1
Investors
3
distinct backers
Active since
2016-02
latest 2016-02

Funding by year

EUR raised per year

Funding rounds

1 rounds
DateStageAmountInvestors
2016-03-01Series A€2.8MBoehringer Ingelheim Venture Fund,High-Tech Gr√ºnderfonds (HTGF),VI PartnersView deal →

Exit

Type
acquisition
Date
Nov 2019
Value
€325M
Acquiror
Boehringer Ingelheim (Germany)

Investors

3
Boehringer Ingelheim Venture FundHigh-Tech Gründerfonds (HTGF)VI Partners

Related news

Similar companies

same sector or country